Nathan Sandbo, MD

Education

• University of Minnesota – Twin Cities, Minneapolis, Minnesota - MD
• University of Chicago Hospitals, Chicago, Illinois – Residency in Internal Medicine
• University of Chicago – Fellowship in Pulmonary and Critical Care Medicine

Professional Activities

Dr. Nathan Sandbo is a faculty member in the Division of Allergy, Pulmonary and Critical Care Medicine within the Department of Medicine and the Director of the University of Wisconsin-Madison Pulmonary Fibrosis Foundation Care Center. Dr. Sandbo is a member of numerous professional societies including the American Thoracic Society, the American College of Chest Physicians, Central Society for Clinical and Translational Research, and the American Society of Matrix Biology.

Clinical Specialties

Dr. Sandbo’s clinical emphasis is on the diagnosis and management of interstitial lung diseases (ILDs), such as idiopathic pulmonary fibrosis. His clinics focus on ILD and currently interface with the interstitial lung disease group at the University of Wisconsin, the pathophysiology of critical illness, and work as a critical care service attending in the Trauma and Life Support Center (TLC) and Neuroscience Intensive Care Unit (NeuroICU).

Research Interests

Dr. Sandbo’s laboratory-based research program focuses on fibroblast biology and signaling in the context of tissue remodeling and pulmonary fibrosis with an emphasis on the interaction between cell shape/cytoskeletal reorganization and associated downstream intracellular signaling/transcriptional regulation in this context. Elucidation of these signaling pathways has implications for the cross-talk between mechanical stimuli and traditional soluble and paracrine mediators of fibroblast activation (TGF-beta, G-protein coupled receptor agonists, etc).